Scientists have developed a new
drug capsule that remains in the stomach for up to two weeks after being
swallowed, gradually releasing its payload, paving the way for a long acting
pill that may effectively treat malaria and many other diseases. This type of
drug delivery could replace inconvenient regimens that require repeated doses,
which would help to overcome one of the major obstacles to treating and
potentially eliminating diseases such as malaria. Researchers at Massachusetts
Institute of Technology (MIT) and Brigham and Women’s Hospital in the United
States used this approach to deliver a drug called ivermectin, which they
believe could aid in malaria elimination efforts.
No comments:
Post a Comment